Inhibition of Cytokine-Induced NF-κB Activation by Adenovirus-Mediated Expression of a NF-κB Super-Repressor Prevents β-Cell Apoptosis

Diabetes

Volumn 50, Issue 10, 2001, Pages 2219-2224

  Heimberg, Harry ^a   Heremans, Yves ^a   Jobin, Christian ^b   Leemans, Ruth ^a   Cardozo, Alessandra K ^a   Darville, Martine ^a   Eizirik, Décio L ^a  

^a DIABETES RESEARCH CENTER   (Belgium)

^b IL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1;

ADENOVIRUS; ANIMAL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL SURVIVAL; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION; GENE TRANSFER; GENE VECTOR; GENETICS; MALE; PANCREAS ISLET; PHYSIOLOGY; RAT; WISTAR RAT;

ADENOVIRIDAE; ANIMALS; APOPTOSIS; CELL SURVIVAL; CELLS, CULTURED; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; I-KAPPA B PROTEINS; INTERFERON TYPE II; INTERLEUKIN-1; ISLETS OF LANGERHANS; MALE; NF-KAPPA B; RATS; RATS, WISTAR;

EID: 0035488777     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.50.10.2219     Document Type: Article

References (35)

1. Mandrup-Poulsen T: The role of interleukin-1 in the pathogenesis of IDDM. Diabetologia 39:1005-1029, 1996
2. Eizirik DL, Pavlovic D: Is there a role for nitric oxide in beta-cell dysfunction and damage in IDDM? Diabete Metab Rev 1:1:293-307, 1997
3. Rabinovitch A: An update on cytokines in the pathogenesis of insulin-dependent diabetes niellitus. Diabete Metab Rev 14:129-151, 1998
4. Eizirik DL, Darville MI: β-Cell apoptosis and defense mechanisms: lessons from type 1 diabetes. Diabetes 50 (Suppl. 1):S64-S69, 2001
5. Cardozo AK, Kruhøffer M, Leeman R, Ørtonft T, Eizirik DL: Identification of novel cytokine-induced genes in pancreatic β-cells by high-density oligonucleotide arrays. Diabetes 50:909-920, 2001
6. Saldeen J, Welsh N: Interleukin-1 β induced activation of NF-κB in insulin producing RINm5F cells is prevented by the protease inhibitor N alpha-ptosyl-L-lysine chloromethylketone. Biochem Biophys Res Commun 203: 149-155, 1994
7. Bedoya FJ, Flodstrom M, Eizirik DL: Pyrrolidine dithiocarbamate prevents IL-1-induced nitric oxide synthase mRNA, but not superoxide dismutase mRNA, in insulin producing cells. Biochem Biophys Res Commun 210: 816-822, 1995
8. Darville MI, Eizirik DL: Regulation by cytokines of the inducible nitric oxide synthase promoter in insulin-producing cells. Diabetologia 41:1101-1108, 1998
9. 8a. Darville MI, Eizirik DL: Cytokine induction of Fas gene expression in insulin-producing cells requires the transcription factors NK-κB and C/EBP. Diabetes 50:1741-1748, 2001
10. Darville MI, Ho YS, Eizirik DL: NF-κB is required for cytokine-induced manganese superoxide dismutase expression in insulin-producing cells. Endocrinology 141:153-162, 2000
11. Barkett M, Gilmore TD: Control of apoptosis by Rel/NF-κB transcription factors. Oncogene 18:6910-6924, 1999
12. Karin M: How NF-κB is activated: the role of the IκB kinase (IKK) complex. Oncogene 18:6867-6874, 1999
13. Pahl HL: Activators and target genes of Rel/NF-κB transcription factors. Oncogene 18:6853-6866, 1999
14. Brown K, Gerstberger S, Carlson L, Franzoso G, Siebenlist U: Control of IκB-α proteolysis by site-specific, signal-induced phosphorylation. Science 267:1485-14888, 1995
15. Jobin C, Panja A, Hellerbrand C, Iimuro Y, Didonato J, Brenner DA, Sartor, RB: Inhibition of proinflammatory molecule production by adenovirusmediated expression of a nuclear factor κB super-repressor in human intestinal epithelial cells. J Immunol 160:41041-41048, 1998
16. Hellerbrand C, Jobin C, Iimuro Y, Licato L, Sartor RB, Brenner DA: Inhibition of NF-κB in activated rat hepatic stellate cells by proteasome inhibitors and an IκB super-repressor. Hepatology 27:1285-1295, 1998
17. Pipeleers DG, in't Veld PA, Van de Winkel M, Maes E, Schuit FC, Gepts W: A new in vitro model for the study of pancreatic A and B cells. Endocrinology 117:806-816, 1985
18. Ling Z, Hannaert JC, Pipeleers D: Effect of nutrients, hormones and serum on survival of rat islet beta cells in culture. Diabetologia 37:15-21, 1994
19. Ling Z, Chen M-C, Smismans A, Pavlovic D, Schuit F, Eizirik DL, Pipeleers DG: Intercellular differences in interleukin-1β-induced suppression of insulin synthesis and stimulation of noninsulin protein synthesis by rat pancreatic β-cells. Endocrinology 139:1540-1545, 1998
20. Chen MC, Schuit F, Eizirik DL: Identification of IL-1β-induced messenger RNAs in rat pancreatic beta cells by differential display of messenger RNA. Diabetologia 42:1199-1203, 1999
21. / ). Diabetes 49:1116-1122, 2000
22. Heimberg H, Bouwens L, Heremans Y, Van De Casteele M, Lefebvre V, Pipeleers D: Adult human pancreatic duct and islet cells exhibit similarities in expression and differences in phosphorylation and complex formation of the homeodomain protein Ipf-1. Diabetes 49:571-579, 2000
23. Eizirik DL, Björklund A, Cagliero E: Genotoxic agents increase expression of growth arrest and DNA damage-inducible genes gadd 153 and gadd 45 in rat pancreatic islets. Diabetes 42:738-745, 1993
24. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR: Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal. Biochem 126:131-138, 1982
25. Delaney CA, Pavlovic D, Hoorens A, Pipeleers DG, Eizirik DL: Cytokines induce deoxyribonucleic acid strand breaks and apoptosis in human pancreatic islet cells. Endocrinology 138:2610-2614, 1997
26. Pavlovic D, Andersen NA, Mandrup-Poulsen T, Eizirik DL: Activation of extracellular signal-regulated kinase (ERK)1/2 contributes to cytokine-induced apoptosis in purified rat pancreatic β-cells. Eur Cytokine Netw 11:267-274, 2000
27. Hoorens A, Van de Casteele M, Moppel G, Pipeleers D: Glucose promotes survival of rat pancreatic beta cells by activating synthesis of proteins which suppress a constitutive apoptotic program. J Clin Invest 98:1568-1574, 1996
28. Pavlovic D, Chen MC, Gysemans CA, Mathieu C, Eizirik DL: The role of Interferon regulatory factor-1 in cytokine-induced mRNA expression and cell death in murine pancreatic β-cells. Eur Cytokine Netw 10:403-412, 1999
29. Liu HS, Jan MS, Chou CK, Phen PH, Ke I: Is green fluorescence protein toxic to the living cells? Biochem Biophys Res Commun 260:712-717, 1999
30. Ingelsson E, Saldeen J, Welsh N: Islet expression of perform, Fas/Apo1 and interleukin-1 converting enzyme (ICE) in non-obese diabetic (NOD) mice. Immunol Lett 63:125-129, 1998
31. Suarez-Pinzon W, Sorenson O, Bleackey RS, Elliot JF, Rajotte RV, Rabinovitch A: β-Cell destruction in NOD mice correlates with Fas (CD95) expression on β-cells and proinflammatory cytokine expression in islets. Diabetes 48:21-28, 1999
32. Amrani A, Verdaguer J, Thiessen S, Bou S, Santamaria P: IL-1a, IL-1β, and IFN-γ mark β cells for Fas-dependent destruction by diabetogenic CD4 + T lymphocytes. J Clin Invest 105:459-468, 2000
33. Moriwaki M, Itoh N, Miyagawa J, Yamamoto K, Imagawa A, Yamagata K, Iwahashi H, Nakajima H, Namba M, Nagata S, Hanafusa T, Matsuzawa Y: Fas and Fas ligand expression in inflamed islets in pancreas sections of patients with recent-onset type I diabetes mellitus. Diabetologia 42:1332-1340, 1999
34. Stassi G, De Mari R, Trucco G, Rudert W, Testi R, Galluzzo A, Giordano C, Trucco M: Nitric oxide primes pancreatic β-cells for Fas-mediated destruction in insulin-dependent diabetes mellitus. J Exp Med 186:1193-1200, 1997
35. Giannoukakis N, Rudert WA, Trucco M, Robbins PD: Protection of human islets from the effects of interleukin-1β by adenoviral gene transfer of an IκB repressor. J Biol Chem 275:36509-36513, 2000